| 1 | adjuvant | 9,072 |
| 2 | neoadjuvant | 2,148 |
| 3 | platinum-based | 730 |
| 4 | single-agent | 725 |
| 5 | cisplatin-based | 390 |
| 6 | doublet | 263 |
| 7 | upfront | 189 |
| 8 | anthracycline-based | 172 |
| 9 | hypofractionated | 161 |
| 10 | dose-dense | 158 |
| 11 | myeloablative | 158 |
| 12 | emetogenic | 146 |
| 13 | docetaxel-based | 126 |
| 14 | neo-adjuvant | 107 |
| 15 | taxane-based | 91 |
| 16 | oxaliplatin-based | 81 |
| 17 | gemcitabine-based | 79 |
| 18 | anthracycline-containing | 73 |
| 19 | 5-fu-based | 68 |
| 20 | carboplatin-based | 62 |
| 21 | dose-intensive | 53 |
| 22 | myelosuppressive | 52 |
| 23 | platinum-containing | 50 |
| 24 | interferon-free | 49 |
| 25 | irinotecan-based | 48 |
| 26 | multiagent | 48 |
| 27 | metronomic | 46 |
| 28 | non-platinum | 44 |
| 29 | bevacizumab-based | 40 |
| 30 | fluorouracil-based | 40 |
| 31 | capecitabine-based | 39 |
| 32 | cisplatin-containing | 38 |
| 33 | split-course | 36 |
| 34 | taxane-containing | 36 |
| 35 | doxorubicin-based | 35 |
| 36 | trastuzumab-based | 35 |
| 37 | amlodipine-based | 34 |
| 38 | fluoropyrimidine-based | 34 |
| 39 | dose-escalated | 33 |
| 40 | efavirenz-based | 32 |
| 41 | bortezomib-based | 31 |
| 42 | 5-fluorouracil-based | 30 |
| 43 | nonmyeloablative | 30 |
| 44 | multi-agent | 28 |
| 45 | multifraction | 28 |
| 46 | bevacizumab-containing | 27 |
| 47 | paclitaxel-based | 26 |
| 48 | all-oral | 25 |
| 49 | cetuximab-based | 24 |
| 50 | non-platinum-based | 24 |
| 51 | single-fraction | 24 |
| 52 | pemetrexed-based | 23 |
| 53 | s-1-based | 22 |
| 54 | dose-intense | 21 |
| 55 | post-dilution | 21 |
| 56 | arb-based | 20 |
| 57 | platin-based | 19 |
| 58 | dose-intensified | 18 |
| 59 | trastuzumab-containing | 17 |
| 60 | non-taxane | 16 |
| 61 | docetaxel-containing | 15 |
| 62 | induction-maintenance | 15 |
| 63 | irinotecan-containing | 15 |
| 64 | platinum-doublet | 15 |
| 65 | ifn-free | 14 |
| 66 | paclitaxel-containing | 14 |
| 67 | rituximab-containing | 14 |
| 68 | arb/ccb | 13 |
| 69 | gem-based | 13 |
| 70 | gemcitabine-platinum | 13 |
| 71 | 2nd-line | 12 |
| 72 | doxorubicin-containing | 12 |
| 73 | thalidomide-based | 12 |
| 74 | adjuvant/neoadjuvant | 11 |
| 75 | chemotherapy-based | 11 |
| 76 | continuous-combined | 11 |
| 77 | fludarabine-based | 11 |
| 78 | rifampicin-containing | 11 |
| 79 | rituximab-based | 11 |
| 80 | alkylator-based | 10 |
| 81 | capecitabine-containing | 10 |
| 82 | cyclophosphamide-based | 10 |
| 83 | non-taxane-containing | 10 |
| 84 | oxaliplatin-containing | 10 |
| 85 | remission-induction | 10 |
| 86 | antibody-directed | 9 |
| 87 | sorafenib-based | 9 |
| 88 | thai-cdc | 9 |
| 89 | 5fu-based | 8 |
| 90 | alemtuzumab-based | 8 |
| 91 | anthracycline-taxane-based | 8 |
| 92 | double-drug | 8 |
| 93 | neoadjuvant/adjuvant | 8 |
| 94 | pediatric-inspired | 8 |
| 95 | pemetrexed/platinum | 8 |
| 96 | tbi-based | 8 |
| 97 | 5-fu-containing | 7 |
| 98 | capecitabine-free | 7 |
| 99 | epirubicin-based | 7 |
| 100 | epirubicin-containing | 7 |
| 101 | g-based | 7 |
| 102 | ifosfamide-based | 7 |
| 103 | interferon-containing | 7 |
| 104 | paclitaxel-cisplatin | 7 |
| 105 | paclitaxel/platinum | 7 |
| 106 | platinum-taxane | 7 |
| 107 | shorter-course | 7 |
| 108 | tpz/cis | 7 |
| 109 | anthracycline/taxane-based | 6 |
| 110 | charged-particle | 6 |
| 111 | chop-like | 6 |
| 112 | cisplatinum-based | 6 |
| 113 | cns-directed | 6 |
| 114 | combination-platinum | 6 |
| 115 | fu-based | 6 |
| 116 | hd-mtx-based | 6 |
| 117 | lpv/r-containing | 6 |
| 118 | more-intense | 6 |
| 119 | multicycle | 6 |
| 120 | non-cisplatin | 6 |
| 121 | platinum-paclitaxel | 6 |
| 122 | stavudine-based | 6 |
| 123 | vinorelbine-based | 6 |
| 124 | anthracycline-taxane | 5 |
| 125 | azithromycin-containing | 5 |
| 126 | bone-directed | 5 |
| 127 | cisplatin-fluorouracil | 5 |
| 128 | concurrent-adjuvant | 5 |
| 129 | cytarabine-containing | 5 |
| 130 | enfuvirtide-based | 5 |
| 131 | erlotinib-based | 5 |
| 132 | fluorouracil-containing | 5 |
| 133 | golfig | 5 |
| 134 | maintenance/consolidation | 5 |
| 135 | non-anthracycline-based | 5 |
| 136 | non-anthracycline-containing | 5 |
| 137 | non-cisplatin-based | 5 |
| 138 | noncross-resistant | 5 |
| 139 | r-chop-like | 5 |
| 140 | raltitrexed-based | 5 |
| 141 | taxanes-based | 5 |
| 142 | temozolomide-based | 5 |
| 143 | vglut2-mediated | 5 |
| 144 | ace-i-arb | 4 |
| 145 | boc-based | 4 |
| 146 | bsc/sc | 4 |
| 147 | carboplatin-containing | 4 |
| 148 | cddp-based | 4 |
| 149 | gastro-entero-pancreatic | 4 |
| 150 | mitoxantrone-based | 4 |
| 151 | nonplatinum-based | 4 |
| 152 | postlumpectomy | 4 |
| 153 | test-guided | 4 |
| 154 | tmz-based | 4 |
| 155 | y-90-it | 4 |
| 156 | 2-agent | 3 |
| 157 | 2-cda-based | 3 |
| 158 | 6-cycle | 3 |
| 159 | abc-containing | 3 |
| 160 | abc/3tc-based | 3 |
| 161 | amoxicillin-metronidazole | 3 |
| 162 | anthracycline-comprising | 3 |
| 163 | anthracyclines-based | 3 |
| 164 | aspirin-combination | 3 |
| 165 | atra-based | 3 |
| 166 | cefotaxime-based | 3 |
| 167 | ceftazidime-containing | 3 |
| 168 | chemo-hormonal | 3 |
| 169 | chemoradiotherapeutic | 3 |
| 170 | cis-platinum-based | 3 |
| 171 | cmf-based | 3 |
| 172 | docetaxel-platinum | 3 |
| 173 | duvaxyn | 3 |
| 174 | first-course | 3 |
| 175 | fluoropyrimidine-containing | 3 |
| 176 | folfox-based | 3 |
| 177 | gemfufol | 3 |
| 178 | induction-concurrent | 3 |
| 179 | intraganglionar | 3 |
| 180 | involved-node | 3 |
| 181 | lung-toxic | 3 |
| 182 | lymphoma-directed | 3 |
| 183 | multiple-agent | 3 |
| 184 | nicoderm | 3 |
| 185 | nitrosourea-based | 3 |
| 186 | non-paclitaxel | 3 |
| 187 | nonalkylating | 3 |
| 188 | pacco | 3 |
| 189 | platinum-gemcitabine | 3 |
| 190 | platinum/taxane-based | 3 |
| 191 | sorafenib-containing | 3 |
| 192 | t-based | 3 |
| 193 | tam+hcq | 3 |
| 194 | therapeutic-dose | 3 |
| 195 | trimethoprim-based | 3 |
| 196 | ultra-short-course | 3 |
| 197 | vincristine-based | 3 |
| 198 | vinorelbine/gemcitabine | 3 |
| 199 | 'adjuvant | 2 |
| 200 | 'dose-dense | 2 |
| 201 | 12-step-oriented | 2 |
| 202 | 5-fluorouracil/mitomycin | 2 |
| 203 | abvd-like | 2 |
| 204 | adriamycin-based | 2 |
| 205 | adriamycin-containing | 2 |
| 206 | amlodipine±perindopril-based | 2 |
| 207 | anti-egfr-based | 2 |
| 208 | anti-folate | 2 |
| 209 | atv-containing | 2 |
| 210 | bleed-preventive | 2 |
| 211 | capecitabine/bolus | 2 |
| 212 | carboplatin/ifosfamide | 2 |
| 213 | cddp-containing | 2 |
| 214 | chemotherapy/radiation | 2 |
| 215 | cis-platin-based | 2 |
| 216 | cisplatin/ifosfamide-based | 2 |
| 217 | combination-agent | 2 |
| 218 | conventional-adult | 2 |
| 219 | conventionally-dosed | 2 |
| 220 | cyclophosphamide-containing | 2 |
| 221 | cyclophosphamide-doxorubicin-based | 2 |
| 222 | decitabine-based | 2 |
| 223 | dose-modified | 2 |
| 224 | doxycycline-containing | 2 |
| 225 | efonidipine-based | 2 |
| 226 | emtricitabine-containing | 2 |
| 227 | epimacular | 2 |
| 228 | frequently-repeated | 2 |
| 229 | glial-mediated | 2 |
| 230 | go-based | 2 |
| 231 | hepatic-artery | 2 |
| 232 | home-exercises | 2 |
| 233 | hydroxyurea-containing | 2 |
| 234 | ics-containing | 2 |
| 235 | ifn-alpha-containing | 2 |
| 236 | immunocytokine | 2 |
| 237 | indirect-acting | 2 |
| 238 | interleukin-2-based | 2 |
| 239 | irinotecan/oxaliplatin | 2 |
| 240 | iv/ip | 2 |
| 241 | levofloxacin-amoxicillin | 2 |
| 242 | lower-dosage | 2 |
| 243 | metabolism-regulating | 2 |
| 244 | multiple-fraction | 2 |
| 245 | ndp-based | 2 |
| 246 | neoadjuvante | 2 |
| 247 | neodjuvant | 2 |
| 248 | non-asct | 2 |
| 249 | non-bevacizumab-containing | 2 |
| 250 | non-pemetrexed | 2 |
| 251 | non-taxane-based | 2 |
| 252 | noncisplatin-based | 2 |
| 253 | nsaid-anticoagulant | 2 |
| 254 | observation/no | 2 |
| 255 | oxaliplatin-/irinotecan-containing | 2 |
| 256 | placebo-containing | 2 |
| 257 | platinum-combination | 2 |
| 258 | platinum/paclitaxel-based | 2 |
| 259 | postneoadjuvant | 2 |
| 260 | preneoadjuvant | 2 |
| 261 | prognosis-modifying | 2 |
| 262 | radiotherapy.- | 2 |
| 263 | rchop | 2 |
| 264 | resective/regenerative | 2 |
| 265 | standard-efficacy | 2 |
| 266 | thermo-targeted | 2 |
| 267 | vinorelbine-combined | 2 |
| 268 | whole-bladder | 2 |
| 269 | 'metronomic | 1 |
| 270 | -1.58+/-0.30 | 1 |
| 271 | -intensified | 1 |
| 272 | 16-fraction | 1 |
| 273 | 2-dosage | 1 |
| 274 | 26-days | 1 |
| 275 | 28℃± | 1 |
| 276 | 3-n-hydroxymethyl | 1 |
| 277 | 3d-planned | 1 |
| 278 | 5-flurouracil-based | 1 |
| 279 | 5ari-containing | 1 |
| 280 | abc+3tc-based | 1 |
| 281 | ac-based | 1 |
| 282 | ac→tx | 1 |
| 283 | adjuvant/palliative | 1 |
| 284 | adminster | 1 |
| 285 | alkylating-agent | 1 |
| 286 | amoxicillin-nitroimidazole | 1 |
| 287 | analgesic/spasmolytic | 1 |
| 288 | anthracyclin-containing | 1 |
| 289 | anthracycline-ara-c | 1 |
| 290 | anthracycline-trastuzumab-containing | 1 |
| 291 | anthracycline/mitomycin-containing | 1 |
| 292 | anti-cd20-containing | 1 |
| 293 | anti-tritrichomonial | 1 |
| 294 | antithrombotic/anticoagulant | 1 |
| 295 | aplasive | 1 |
| 296 | arac-based | 1 |
| 297 | artemisinin-containing | 1 |
| 298 | asthma-treatment | 1 |
| 299 | atazanavir/ritonavir-containing | 1 |
| 300 | ato/conventional | 1 |
| 301 | azd6244-based | 1 |
| 302 | bev-containing | 1 |
| 303 | bevacizumab/taxane-based | 1 |
| 304 | biopsy/pre-operative | 1 |
| 305 | busulfan+cyclophosphamide-based | 1 |
| 306 | capacitabine-based | 1 |
| 307 | chemotherapy-enhanced | 1 |
| 308 | chlorambucil-containing | 1 |
| 309 | cholecystokinin-positive | 1 |
| 310 | chop-based | 1 |
| 311 | cisplatin-/carboplatin-based | 1 |
| 312 | cisplatin-a | 1 |
| 313 | cisplatin-etoposide-bleomycin | 1 |
| 314 | cisplatin-hdfl | 1 |
| 315 | contraria | 1 |
| 316 | copp/abvd-like | 1 |
| 317 | cpt-11-based | 1 |
| 318 | current-standard | 1 |
| 319 | cyclophosphamide/methotrexate/5-fluorouracil-based | 1 |
| 320 | daunorubicin-based | 1 |
| 321 | ddp+5-fu | 1 |
| 322 | delamanid-containing | 1 |
| 323 | dentifrice/mouthrinse | 1 |
| 324 | docetaxel-anthracycline-based | 1 |
| 325 | docetaxel-cisplatin-5-fu | 1 |
| 326 | dose-densified | 1 |
| 327 | double-boosted | 1 |
| 328 | doublet-based | 1 |
| 329 | dox-containing | 1 |
| 330 | e3200 | 1 |
| 331 | efavirenz-to | 1 |
| 332 | effective/tolerable | 1 |
| 333 | effectof | 1 |
| 334 | eisplatin | 1 |
| 335 | embolization+systemic | 1 |
| 336 | entero-hypothalamic | 1 |
| 337 | epi-contained | 1 |
| 338 | epirubicin-paclitaxel-cyclophosphamide | 1 |
| 339 | erlotinib/capecitabine | 1 |
| 340 | estramustine-based | 1 |
| 341 | estrogen-mimicking | 1 |
| 342 | etoposide-doxorubicine-based | 1 |
| 343 | fac-only | 1 |
| 344 | fast-reacting | 1 |
| 345 | fe100c | 1 |
| 346 | five-course | 1 |
| 347 | fluorinated-pyrimidine-based | 1 |
| 348 | fluoropyrimidine/oxaliplatin-based | 1 |
| 349 | fluoropyrimidines+oxaliplatin+b-based | 1 |
| 350 | fluorouacil | 1 |
| 351 | folfox/folfiri/xelox | 1 |
| 352 | forewater | 1 |
| 353 | freund׳s | 1 |
| 354 | furosemide-sparing | 1 |
| 355 | g-csf-supported | 1 |
| 356 | gemcitabine/epirubicin/taxane | 1 |
| 357 | glucose-sparing | 1 |
| 358 | gp-containing | 1 |
| 359 | hepatic-artery-based | 1 |
| 360 | higher-cumulative-dosage | 1 |
| 361 | higher-line | 1 |
| 362 | hydroxyurea-based | 1 |
| 363 | ifn-α-free | 1 |
| 364 | ifosfamide-containing | 1 |
| 365 | ifosfamide/actinomycin/vincristine-based | 1 |
| 366 | ilps-based | 1 |
| 367 | immune-system-modifying | 1 |
| 368 | indinavir-based | 1 |
| 369 | indirectly-with | 1 |
| 370 | intensified/dose-dense | 1 |
| 371 | intensive-induction | 1 |
| 372 | interval-free | 1 |
| 373 | intraperitoneal-containing | 1 |
| 374 | intravesicle | 1 |
| 375 | introvesical | 1 |
| 376 | irinotecan-platinum | 1 |
| 377 | ixabepilone-based | 1 |
| 378 | l-asp-based | 1 |
| 379 | lamivudine/stavudine-based | 1 |
| 380 | less-intensified | 1 |
| 381 | leucovorin/5-fluorouracil | 1 |
| 382 | limbus-based | 1 |
| 383 | low-lose | 1 |
| 384 | marrow-toxic | 1 |
| 385 | matrix-c | 1 |
| 386 | medium-to-high-dose | 1 |
| 387 | methotrexate-5-fluorouracil | 1 |
| 388 | mucositis-inducing | 1 |
| 389 | naodjuvant | 1 |
| 390 | nap-based | 1 |
| 391 | neoadjunctive | 1 |
| 392 | neoadjuvant/preoperative | 1 |
| 393 | no-pld-based | 1 |
| 394 | non-alkylating | 1 |
| 395 | non-hdtx | 1 |
| 396 | non-i | 1 |
| 397 | non-ifosfamide-containing | 1 |
| 398 | non-oxaliplatin | 1 |
| 399 | non-oxaliplatin-based | 1 |
| 400 | non-platin-containing | 1 |
| 401 | non-tdf-containing | 1 |
| 402 | non-temozolomide | 1 |
| 403 | non-topotecan | 1 |
| 404 | non-trastuzumab-based | 1 |
| 405 | noncyclophosphamide-based | 1 |
| 406 | nonefavirenz-containing | 1 |
| 407 | nonirinotecan-containing | 1 |
| 408 | nonplatinum-containing | 1 |
| 409 | noradrenergic/specific | 1 |
| 410 | normofractionated | 1 |
| 411 | nrti-free | 1 |
| 412 | nrti-only | 1 |
| 413 | oestrogens-progestin | 1 |
| 414 | ondansetron-containing | 1 |
| 415 | one-year-long | 1 |
| 416 | orpostradiation | 1 |
| 417 | p-g | 1 |
| 418 | p/fec | 1 |
| 419 | paclitaxel-carboplatin-based | 1 |
| 420 | paclitaxel/anthracycline-containing | 1 |
| 421 | paclitaxel/carboplatin/gemcitabine-based | 1 |
| 422 | paclitaxel/platinum-containing | 1 |
| 423 | pamphlet-delivered | 1 |
| 424 | pasture-feeding | 1 |
| 425 | pemetrexed-plus-platinum | 1 |
| 426 | periodontitis-driven | 1 |
| 427 | platinum+taxane-based | 1 |
| 428 | platinum-vinblastine-bleomycin | 1 |
| 429 | pld-containing | 1 |
| 430 | pontospinal | 1 |
| 431 | pre-taxane | 1 |
| 432 | preenucleation | 1 |
| 433 | preirradiatory | 1 |
| 434 | preoperative/neoadjuvant | 1 |
| 435 | ptz-sensitive | 1 |
| 436 | quinolone-containing | 1 |
| 437 | r-high-dose | 1 |
| 438 | receive/receiving | 1 |
| 439 | remote-monitoring | 1 |
| 440 | repaglinide-containing | 1 |
| 441 | rfh-enhanced | 1 |
| 442 | sc-ril-2/sc-rifn-alpha2a/iv-5-fu-based | 1 |
| 443 | sclc.second-line | 1 |
| 444 | senescence-inducing | 1 |
| 445 | septo-hippocampal | 1 |
| 446 | serotonin-producing | 1 |
| 447 | sirt+standard | 1 |
| 448 | sit-related | 1 |
| 449 | srs-induced | 1 |
| 450 | standard-interval | 1 |
| 451 | stem-cell-supported | 1 |
| 452 | subscleral | 1 |
| 453 | supraclavicular/axillary | 1 |
| 454 | taxane/anthracycline-based | 1 |
| 455 | taxane/platinum-based | 1 |
| 456 | temsirolimus-based | 1 |
| 457 | thrombolytic-based | 1 |
| 458 | timed-sequential | 1 |
| 459 | to/during/after | 1 |
| 460 | trials-herceptin | 1 |
| 461 | vad-like | 1 |
| 462 | vomiting.a | 1 |
| 463 | x-solve | 1 |
| 464 | zidovudine/lamivudine-containing | 1 |
| 465 | zmyl-cisplatin | 1 |
| 466 | |±3/2〉 | 1 |
| 1 | 'adjuvant | 2 |
| 2 | 'dose-dense | 2 |
| 3 | 'metronomic | 1 |
| 4 | -1.58+/-0.30 | 1 |
| 5 | -intensified | 1 |
| 6 | 12-step-oriented | 2 |
| 7 | 16-fraction | 1 |
| 8 | 2-agent | 3 |
| 9 | 2-cda-based | 3 |
| 10 | 2-dosage | 1 |
| 11 | 26-days | 1 |
| 12 | 28℃± | 1 |
| 13 | 2nd-line | 12 |
| 14 | 3-n-hydroxymethyl | 1 |
| 15 | 3d-planned | 1 |
| 16 | 5-fluorouracil-based | 30 |
| 17 | 5-fluorouracil/mitomycin | 2 |
| 18 | 5-flurouracil-based | 1 |
| 19 | 5-fu-based | 68 |
| 20 | 5-fu-containing | 7 |
| 21 | 5ari-containing | 1 |
| 22 | 5fu-based | 8 |
| 23 | 6-cycle | 3 |
| 24 | abc+3tc-based | 1 |
| 25 | abc-containing | 3 |
| 26 | abc/3tc-based | 3 |
| 27 | abvd-like | 2 |
| 28 | ac-based | 1 |
| 29 | ace-i-arb | 4 |
| 30 | ac→tx | 1 |
| 31 | adjuvant | 9,072 |
| 32 | adjuvant/neoadjuvant | 11 |
| 33 | adjuvant/palliative | 1 |
| 34 | adminster | 1 |
| 35 | adriamycin-based | 2 |
| 36 | adriamycin-containing | 2 |
| 37 | alemtuzumab-based | 8 |
| 38 | alkylating-agent | 1 |
| 39 | alkylator-based | 10 |
| 40 | all-oral | 25 |
| 41 | amlodipine-based | 34 |
| 42 | amlodipine±perindopril-based | 2 |
| 43 | amoxicillin-metronidazole | 3 |
| 44 | amoxicillin-nitroimidazole | 1 |
| 45 | analgesic/spasmolytic | 1 |
| 46 | anthracyclin-containing | 1 |
| 47 | anthracycline-ara-c | 1 |
| 48 | anthracycline-based | 172 |
| 49 | anthracycline-comprising | 3 |
| 50 | anthracycline-containing | 73 |
| 51 | anthracycline-taxane | 5 |
| 52 | anthracycline-taxane-based | 8 |
| 53 | anthracycline-trastuzumab-containing | 1 |
| 54 | anthracycline/mitomycin-containing | 1 |
| 55 | anthracycline/taxane-based | 6 |
| 56 | anthracyclines-based | 3 |
| 57 | anti-cd20-containing | 1 |
| 58 | anti-egfr-based | 2 |
| 59 | anti-folate | 2 |
| 60 | anti-tritrichomonial | 1 |
| 61 | antibody-directed | 9 |
| 62 | antithrombotic/anticoagulant | 1 |
| 63 | aplasive | 1 |
| 64 | arac-based | 1 |
| 65 | arb-based | 20 |
| 66 | arb/ccb | 13 |
| 67 | artemisinin-containing | 1 |
| 68 | aspirin-combination | 3 |
| 69 | asthma-treatment | 1 |
| 70 | atazanavir/ritonavir-containing | 1 |
| 71 | ato/conventional | 1 |
| 72 | atra-based | 3 |
| 73 | atv-containing | 2 |
| 74 | azd6244-based | 1 |
| 75 | azithromycin-containing | 5 |
| 76 | bev-containing | 1 |
| 77 | bevacizumab-based | 40 |
| 78 | bevacizumab-containing | 27 |
| 79 | bevacizumab/taxane-based | 1 |
| 80 | biopsy/pre-operative | 1 |
| 81 | bleed-preventive | 2 |
| 82 | boc-based | 4 |
| 83 | bone-directed | 5 |
| 84 | bortezomib-based | 31 |
| 85 | bsc/sc | 4 |
| 86 | busulfan+cyclophosphamide-based | 1 |
| 87 | capacitabine-based | 1 |
| 88 | capecitabine-based | 39 |
| 89 | capecitabine-containing | 10 |
| 90 | capecitabine-free | 7 |
| 91 | capecitabine/bolus | 2 |
| 92 | carboplatin-based | 62 |
| 93 | carboplatin-containing | 4 |
| 94 | carboplatin/ifosfamide | 2 |
| 95 | cddp-based | 4 |
| 96 | cddp-containing | 2 |
| 97 | cefotaxime-based | 3 |
| 98 | ceftazidime-containing | 3 |
| 99 | cetuximab-based | 24 |
| 100 | charged-particle | 6 |
| 101 | chemo-hormonal | 3 |
| 102 | chemoradiotherapeutic | 3 |
| 103 | chemotherapy-based | 11 |
| 104 | chemotherapy-enhanced | 1 |
| 105 | chemotherapy/radiation | 2 |
| 106 | chlorambucil-containing | 1 |
| 107 | cholecystokinin-positive | 1 |
| 108 | chop-based | 1 |
| 109 | chop-like | 6 |
| 110 | cis-platin-based | 2 |
| 111 | cis-platinum-based | 3 |
| 112 | cisplatin-/carboplatin-based | 1 |
| 113 | cisplatin-a | 1 |
| 114 | cisplatin-based | 390 |
| 115 | cisplatin-containing | 38 |
| 116 | cisplatin-etoposide-bleomycin | 1 |
| 117 | cisplatin-fluorouracil | 5 |
| 118 | cisplatin-hdfl | 1 |
| 119 | cisplatin/ifosfamide-based | 2 |
| 120 | cisplatinum-based | 6 |
| 121 | cmf-based | 3 |
| 122 | cns-directed | 6 |
| 123 | combination-agent | 2 |
| 124 | combination-platinum | 6 |
| 125 | concurrent-adjuvant | 5 |
| 126 | continuous-combined | 11 |
| 127 | contraria | 1 |
| 128 | conventional-adult | 2 |
| 129 | conventionally-dosed | 2 |
| 130 | copp/abvd-like | 1 |
| 131 | cpt-11-based | 1 |
| 132 | current-standard | 1 |
| 133 | cyclophosphamide-based | 10 |
| 134 | cyclophosphamide-containing | 2 |
| 135 | cyclophosphamide-doxorubicin-based | 2 |
| 136 | cyclophosphamide/methotrexate/5-fluorouracil-based | 1 |
| 137 | cytarabine-containing | 5 |
| 138 | daunorubicin-based | 1 |
| 139 | ddp+5-fu | 1 |
| 140 | decitabine-based | 2 |
| 141 | delamanid-containing | 1 |
| 142 | dentifrice/mouthrinse | 1 |
| 143 | docetaxel-anthracycline-based | 1 |
| 144 | docetaxel-based | 126 |
| 145 | docetaxel-cisplatin-5-fu | 1 |
| 146 | docetaxel-containing | 15 |
| 147 | docetaxel-platinum | 3 |
| 148 | dose-dense | 158 |
| 149 | dose-densified | 1 |
| 150 | dose-escalated | 33 |
| 151 | dose-intense | 21 |
| 152 | dose-intensified | 18 |
| 153 | dose-intensive | 53 |
| 154 | dose-modified | 2 |
| 155 | double-boosted | 1 |
| 156 | double-drug | 8 |
| 157 | doublet | 263 |
| 158 | doublet-based | 1 |
| 159 | dox-containing | 1 |
| 160 | doxorubicin-based | 35 |
| 161 | doxorubicin-containing | 12 |
| 162 | doxycycline-containing | 2 |
| 163 | duvaxyn | 3 |
| 164 | e3200 | 1 |
| 165 | efavirenz-based | 32 |
| 166 | efavirenz-to | 1 |
| 167 | effective/tolerable | 1 |
| 168 | effectof | 1 |
| 169 | efonidipine-based | 2 |
| 170 | eisplatin | 1 |
| 171 | embolization+systemic | 1 |
| 172 | emetogenic | 146 |
| 173 | emtricitabine-containing | 2 |
| 174 | enfuvirtide-based | 5 |
| 175 | entero-hypothalamic | 1 |
| 176 | epi-contained | 1 |
| 177 | epimacular | 2 |
| 178 | epirubicin-based | 7 |
| 179 | epirubicin-containing | 7 |
| 180 | epirubicin-paclitaxel-cyclophosphamide | 1 |
| 181 | erlotinib-based | 5 |
| 182 | erlotinib/capecitabine | 1 |
| 183 | estramustine-based | 1 |
| 184 | estrogen-mimicking | 1 |
| 185 | etoposide-doxorubicine-based | 1 |
| 186 | fac-only | 1 |
| 187 | fast-reacting | 1 |
| 188 | fe100c | 1 |
| 189 | first-course | 3 |
| 190 | five-course | 1 |
| 191 | fludarabine-based | 11 |
| 192 | fluorinated-pyrimidine-based | 1 |
| 193 | fluoropyrimidine-based | 34 |
| 194 | fluoropyrimidine-containing | 3 |
| 195 | fluoropyrimidine/oxaliplatin-based | 1 |
| 196 | fluoropyrimidines+oxaliplatin+b-based | 1 |
| 197 | fluorouacil | 1 |
| 198 | fluorouracil-based | 40 |
| 199 | fluorouracil-containing | 5 |
| 200 | folfox-based | 3 |
| 201 | folfox/folfiri/xelox | 1 |
| 202 | forewater | 1 |
| 203 | frequently-repeated | 2 |
| 204 | freund׳s | 1 |
| 205 | fu-based | 6 |
| 206 | furosemide-sparing | 1 |
| 207 | g-based | 7 |
| 208 | g-csf-supported | 1 |
| 209 | gastro-entero-pancreatic | 4 |
| 210 | gem-based | 13 |
| 211 | gemcitabine-based | 79 |
| 212 | gemcitabine-platinum | 13 |
| 213 | gemcitabine/epirubicin/taxane | 1 |
| 214 | gemfufol | 3 |
| 215 | glial-mediated | 2 |
| 216 | glucose-sparing | 1 |
| 217 | go-based | 2 |
| 218 | golfig | 5 |
| 219 | gp-containing | 1 |
| 220 | hd-mtx-based | 6 |
| 221 | hepatic-artery | 2 |
| 222 | hepatic-artery-based | 1 |
| 223 | higher-cumulative-dosage | 1 |
| 224 | higher-line | 1 |
| 225 | home-exercises | 2 |
| 226 | hydroxyurea-based | 1 |
| 227 | hydroxyurea-containing | 2 |
| 228 | hypofractionated | 161 |
| 229 | ics-containing | 2 |
| 230 | ifn-alpha-containing | 2 |
| 231 | ifn-free | 14 |
| 232 | ifn-α-free | 1 |
| 233 | ifosfamide-based | 7 |
| 234 | ifosfamide-containing | 1 |
| 235 | ifosfamide/actinomycin/vincristine-based | 1 |
| 236 | ilps-based | 1 |
| 237 | immune-system-modifying | 1 |
| 238 | immunocytokine | 2 |
| 239 | indinavir-based | 1 |
| 240 | indirect-acting | 2 |
| 241 | indirectly-with | 1 |
| 242 | induction-concurrent | 3 |
| 243 | induction-maintenance | 15 |
| 244 | intensified/dose-dense | 1 |
| 245 | intensive-induction | 1 |
| 246 | interferon-containing | 7 |
| 247 | interferon-free | 49 |
| 248 | interleukin-2-based | 2 |
| 249 | interval-free | 1 |
| 250 | intraganglionar | 3 |
| 251 | intraperitoneal-containing | 1 |
| 252 | intravesicle | 1 |
| 253 | introvesical | 1 |
| 254 | involved-node | 3 |
| 255 | irinotecan-based | 48 |
| 256 | irinotecan-containing | 15 |
| 257 | irinotecan-platinum | 1 |
| 258 | irinotecan/oxaliplatin | 2 |
| 259 | iv/ip | 2 |
| 260 | ixabepilone-based | 1 |
| 261 | l-asp-based | 1 |
| 262 | lamivudine/stavudine-based | 1 |
| 263 | less-intensified | 1 |
| 264 | leucovorin/5-fluorouracil | 1 |
| 265 | levofloxacin-amoxicillin | 2 |
| 266 | limbus-based | 1 |
| 267 | low-lose | 1 |
| 268 | lower-dosage | 2 |
| 269 | lpv/r-containing | 6 |
| 270 | lung-toxic | 3 |
| 271 | lymphoma-directed | 3 |
| 272 | maintenance/consolidation | 5 |
| 273 | marrow-toxic | 1 |
| 274 | matrix-c | 1 |
| 275 | medium-to-high-dose | 1 |
| 276 | metabolism-regulating | 2 |
| 277 | methotrexate-5-fluorouracil | 1 |
| 278 | metronomic | 46 |
| 279 | mitoxantrone-based | 4 |
| 280 | more-intense | 6 |
| 281 | mucositis-inducing | 1 |
| 282 | multi-agent | 28 |
| 283 | multiagent | 48 |
| 284 | multicycle | 6 |
| 285 | multifraction | 28 |
| 286 | multiple-agent | 3 |
| 287 | multiple-fraction | 2 |
| 288 | myeloablative | 158 |
| 289 | myelosuppressive | 52 |
| 290 | naodjuvant | 1 |
| 291 | nap-based | 1 |
| 292 | ndp-based | 2 |
| 293 | neo-adjuvant | 107 |
| 294 | neoadjunctive | 1 |
| 295 | neoadjuvant | 2,148 |
| 296 | neoadjuvant/adjuvant | 8 |
| 297 | neoadjuvant/preoperative | 1 |
| 298 | neoadjuvante | 2 |
| 299 | neodjuvant | 2 |
| 300 | nicoderm | 3 |
| 301 | nitrosourea-based | 3 |
| 302 | no-pld-based | 1 |
| 303 | non-alkylating | 1 |
| 304 | non-anthracycline-based | 5 |
| 305 | non-anthracycline-containing | 5 |
| 306 | non-asct | 2 |
| 307 | non-bevacizumab-containing | 2 |
| 308 | non-cisplatin | 6 |
| 309 | non-cisplatin-based | 5 |
| 310 | non-hdtx | 1 |
| 311 | non-i | 1 |
| 312 | non-ifosfamide-containing | 1 |
| 313 | non-oxaliplatin | 1 |
| 314 | non-oxaliplatin-based | 1 |
| 315 | non-paclitaxel | 3 |
| 316 | non-pemetrexed | 2 |
| 317 | non-platin-containing | 1 |
| 318 | non-platinum | 44 |
| 319 | non-platinum-based | 24 |
| 320 | non-taxane | 16 |
| 321 | non-taxane-based | 2 |
| 322 | non-taxane-containing | 10 |
| 323 | non-tdf-containing | 1 |
| 324 | non-temozolomide | 1 |
| 325 | non-topotecan | 1 |
| 326 | non-trastuzumab-based | 1 |
| 327 | nonalkylating | 3 |
| 328 | noncisplatin-based | 2 |
| 329 | noncross-resistant | 5 |
| 330 | noncyclophosphamide-based | 1 |
| 331 | nonefavirenz-containing | 1 |
| 332 | nonirinotecan-containing | 1 |
| 333 | nonmyeloablative | 30 |
| 334 | nonplatinum-based | 4 |
| 335 | nonplatinum-containing | 1 |
| 336 | noradrenergic/specific | 1 |
| 337 | normofractionated | 1 |
| 338 | nrti-free | 1 |
| 339 | nrti-only | 1 |
| 340 | nsaid-anticoagulant | 2 |
| 341 | observation/no | 2 |
| 342 | oestrogens-progestin | 1 |
| 343 | ondansetron-containing | 1 |
| 344 | one-year-long | 1 |
| 345 | orpostradiation | 1 |
| 346 | oxaliplatin-/irinotecan-containing | 2 |
| 347 | oxaliplatin-based | 81 |
| 348 | oxaliplatin-containing | 10 |
| 349 | p-g | 1 |
| 350 | p/fec | 1 |
| 351 | pacco | 3 |
| 352 | paclitaxel-based | 26 |
| 353 | paclitaxel-carboplatin-based | 1 |
| 354 | paclitaxel-cisplatin | 7 |
| 355 | paclitaxel-containing | 14 |
| 356 | paclitaxel/anthracycline-containing | 1 |
| 357 | paclitaxel/carboplatin/gemcitabine-based | 1 |
| 358 | paclitaxel/platinum | 7 |
| 359 | paclitaxel/platinum-containing | 1 |
| 360 | pamphlet-delivered | 1 |
| 361 | pasture-feeding | 1 |
| 362 | pediatric-inspired | 8 |
| 363 | pemetrexed-based | 23 |
| 364 | pemetrexed-plus-platinum | 1 |
| 365 | pemetrexed/platinum | 8 |
| 366 | periodontitis-driven | 1 |
| 367 | placebo-containing | 2 |
| 368 | platin-based | 19 |
| 369 | platinum+taxane-based | 1 |
| 370 | platinum-based | 730 |
| 371 | platinum-combination | 2 |
| 372 | platinum-containing | 50 |
| 373 | platinum-doublet | 15 |
| 374 | platinum-gemcitabine | 3 |
| 375 | platinum-paclitaxel | 6 |
| 376 | platinum-taxane | 7 |
| 377 | platinum-vinblastine-bleomycin | 1 |
| 378 | platinum/paclitaxel-based | 2 |
| 379 | platinum/taxane-based | 3 |
| 380 | pld-containing | 1 |
| 381 | pontospinal | 1 |
| 382 | post-dilution | 21 |
| 383 | postlumpectomy | 4 |
| 384 | postneoadjuvant | 2 |
| 385 | pre-taxane | 1 |
| 386 | preenucleation | 1 |
| 387 | preirradiatory | 1 |
| 388 | preneoadjuvant | 2 |
| 389 | preoperative/neoadjuvant | 1 |
| 390 | prognosis-modifying | 2 |
| 391 | ptz-sensitive | 1 |
| 392 | quinolone-containing | 1 |
| 393 | r-chop-like | 5 |
| 394 | r-high-dose | 1 |
| 395 | radiotherapy.- | 2 |
| 396 | raltitrexed-based | 5 |
| 397 | rchop | 2 |
| 398 | receive/receiving | 1 |
| 399 | remission-induction | 10 |
| 400 | remote-monitoring | 1 |
| 401 | repaglinide-containing | 1 |
| 402 | resective/regenerative | 2 |
| 403 | rfh-enhanced | 1 |
| 404 | rifampicin-containing | 11 |
| 405 | rituximab-based | 11 |
| 406 | rituximab-containing | 14 |
| 407 | s-1-based | 22 |
| 408 | sc-ril-2/sc-rifn-alpha2a/iv-5-fu-based | 1 |
| 409 | sclc.second-line | 1 |
| 410 | senescence-inducing | 1 |
| 411 | septo-hippocampal | 1 |
| 412 | serotonin-producing | 1 |
| 413 | shorter-course | 7 |
| 414 | single-agent | 725 |
| 415 | single-fraction | 24 |
| 416 | sirt+standard | 1 |
| 417 | sit-related | 1 |
| 418 | sorafenib-based | 9 |
| 419 | sorafenib-containing | 3 |
| 420 | split-course | 36 |
| 421 | srs-induced | 1 |
| 422 | standard-efficacy | 2 |
| 423 | standard-interval | 1 |
| 424 | stavudine-based | 6 |
| 425 | stem-cell-supported | 1 |
| 426 | subscleral | 1 |
| 427 | supraclavicular/axillary | 1 |
| 428 | t-based | 3 |
| 429 | tam+hcq | 3 |
| 430 | taxane-based | 91 |
| 431 | taxane-containing | 36 |
| 432 | taxane/anthracycline-based | 1 |
| 433 | taxane/platinum-based | 1 |
| 434 | taxanes-based | 5 |
| 435 | tbi-based | 8 |
| 436 | temozolomide-based | 5 |
| 437 | temsirolimus-based | 1 |
| 438 | test-guided | 4 |
| 439 | thai-cdc | 9 |
| 440 | thalidomide-based | 12 |
| 441 | therapeutic-dose | 3 |
| 442 | thermo-targeted | 2 |
| 443 | thrombolytic-based | 1 |
| 444 | timed-sequential | 1 |
| 445 | tmz-based | 4 |
| 446 | to/during/after | 1 |
| 447 | tpz/cis | 7 |
| 448 | trastuzumab-based | 35 |
| 449 | trastuzumab-containing | 17 |
| 450 | trials-herceptin | 1 |
| 451 | trimethoprim-based | 3 |
| 452 | ultra-short-course | 3 |
| 453 | upfront | 189 |
| 454 | vad-like | 1 |
| 455 | vglut2-mediated | 5 |
| 456 | vincristine-based | 3 |
| 457 | vinorelbine-based | 6 |
| 458 | vinorelbine-combined | 2 |
| 459 | vinorelbine/gemcitabine | 3 |
| 460 | vomiting.a | 1 |
| 461 | whole-bladder | 2 |
| 462 | x-solve | 1 |
| 463 | y-90-it | 4 |
| 464 | zidovudine/lamivudine-containing | 1 |
| 465 | zmyl-cisplatin | 1 |
| 466 | |±3/2〉 | 1 |
| 1 | radiotherapy.- | 2 |
| 2 | e3200 | 1 |
| 3 | -1.58+/-0.30 | 1 |
| 4 | cisplatin-a | 1 |
| 5 | vomiting.a | 1 |
| 6 | contraria | 1 |
| 7 | arb/ccb | 13 |
| 8 | ace-i-arb | 4 |
| 9 | anthracycline-ara-c | 1 |
| 10 | matrix-c | 1 |
| 11 | fe100c | 1 |
| 12 | thai-cdc | 9 |
| 13 | p/fec | 1 |
| 14 | noradrenergic/specific | 1 |
| 15 | entero-hypothalamic | 1 |
| 16 | embolization+systemic | 1 |
| 17 | metronomic | 46 |
| 18 | 'metronomic | 1 |
| 19 | emetogenic | 146 |
| 20 | gastro-entero-pancreatic | 4 |
| 21 | chemoradiotherapeutic | 3 |
| 22 | analgesic/spasmolytic | 1 |
| 23 | lung-toxic | 3 |
| 24 | marrow-toxic | 1 |
| 25 | bsc/sc | 4 |
| 26 | rfh-enhanced | 1 |
| 27 | chemotherapy-enhanced | 1 |
| 28 | srs-induced | 1 |
| 29 | test-guided | 4 |
| 30 | dose-modified | 2 |
| 31 | dose-densified | 1 |
| 32 | -intensified | 1 |
| 33 | dose-intensified | 18 |
| 34 | less-intensified | 1 |
| 35 | epi-contained | 1 |
| 36 | vinorelbine-combined | 2 |
| 37 | continuous-combined | 11 |
| 38 | 3d-planned | 1 |
| 39 | pamphlet-delivered | 1 |
| 40 | pediatric-inspired | 8 |
| 41 | s-1-based | 22 |
| 42 | cpt-11-based | 1 |
| 43 | interleukin-2-based | 2 |
| 44 | azd6244-based | 1 |
| 45 | 2-cda-based | 3 |
| 46 | nitrosourea-based | 3 |
| 47 | hydroxyurea-based | 1 |
| 48 | atra-based | 3 |
| 49 | fluoropyrimidines+oxaliplatin+b-based | 1 |
| 50 | cetuximab-based | 24 |
| 51 | rituximab-based | 11 |
| 52 | bevacizumab-based | 40 |
| 53 | alemtuzumab-based | 8 |
| 54 | trastuzumab-based | 35 |
| 55 | non-trastuzumab-based | 1 |
| 56 | bortezomib-based | 31 |
| 57 | sorafenib-based | 9 |
| 58 | erlotinib-based | 5 |
| 59 | arb-based | 20 |
| 60 | ac-based | 1 |
| 61 | arac-based | 1 |
| 62 | thrombolytic-based | 1 |
| 63 | boc-based | 4 |
| 64 | abc+3tc-based | 1 |
| 65 | abc/3tc-based | 3 |
| 66 | pemetrexed-based | 23 |
| 67 | raltitrexed-based | 5 |
| 68 | no-pld-based | 1 |
| 69 | ifosfamide-based | 7 |
| 70 | cisplatin/ifosfamide-based | 2 |
| 71 | cyclophosphamide-based | 10 |
| 72 | busulfan+cyclophosphamide-based | 1 |
| 73 | noncyclophosphamide-based | 1 |
| 74 | thalidomide-based | 12 |
| 75 | temozolomide-based | 5 |
| 76 | enfuvirtide-based | 5 |
| 77 | cefotaxime-based | 3 |
| 78 | taxane-based | 91 |
| 79 | platinum+taxane-based | 1 |
| 80 | anthracycline-taxane-based | 8 |
| 81 | non-taxane-based | 2 |
| 82 | bevacizumab/taxane-based | 1 |
| 83 | anthracycline/taxane-based | 6 |
| 84 | platinum/taxane-based | 3 |
| 85 | fludarabine-based | 11 |
| 86 | capacitabine-based | 1 |
| 87 | decitabine-based | 2 |
| 88 | capecitabine-based | 39 |
| 89 | gemcitabine-based | 79 |
| 90 | paclitaxel/carboplatin/gemcitabine-based | 1 |
| 91 | vinorelbine-based | 6 |
| 92 | etoposide-doxorubicine-based | 1 |
| 93 | fluorinated-pyrimidine-based | 1 |
| 94 | fluoropyrimidine-based | 34 |
| 95 | stavudine-based | 6 |
| 96 | lamivudine/stavudine-based | 1 |
| 97 | anthracycline-based | 172 |
| 98 | docetaxel-anthracycline-based | 1 |
| 99 | non-anthracycline-based | 5 |
| 100 | taxane/anthracycline-based | 1 |
| 101 | efonidipine-based | 2 |
| 102 | amlodipine-based | 34 |
| 103 | vincristine-based | 3 |
| 104 | ifosfamide/actinomycin/vincristine-based | 1 |
| 105 | estramustine-based | 1 |
| 106 | ixabepilone-based | 1 |
| 107 | mitoxantrone-based | 4 |
| 108 | cmf-based | 3 |
| 109 | g-based | 7 |
| 110 | tbi-based | 8 |
| 111 | docetaxel-based | 126 |
| 112 | paclitaxel-based | 26 |
| 113 | platinum/paclitaxel-based | 2 |
| 114 | fluorouracil-based | 40 |
| 115 | 5-fluorouracil-based | 30 |
| 116 | cyclophosphamide/methotrexate/5-fluorouracil-based | 1 |
| 117 | 5-flurouracil-based | 1 |
| 118 | amlodipine±perindopril-based | 2 |
| 119 | gem-based | 13 |
| 120 | trimethoprim-based | 3 |
| 121 | platinum-based | 730 |
| 122 | non-platinum-based | 24 |
| 123 | cis-platinum-based | 3 |
| 124 | taxane/platinum-based | 1 |
| 125 | nonplatinum-based | 4 |
| 126 | cisplatinum-based | 6 |
| 127 | irinotecan-based | 48 |
| 128 | epirubicin-based | 7 |
| 129 | daunorubicin-based | 1 |
| 130 | doxorubicin-based | 35 |
| 131 | cyclophosphamide-doxorubicin-based | 2 |
| 132 | adriamycin-based | 2 |
| 133 | platin-based | 19 |
| 134 | cis-platin-based | 2 |
| 135 | oxaliplatin-based | 81 |
| 136 | non-oxaliplatin-based | 1 |
| 137 | fluoropyrimidine/oxaliplatin-based | 1 |
| 138 | carboplatin-based | 62 |
| 139 | paclitaxel-carboplatin-based | 1 |
| 140 | cisplatin-/carboplatin-based | 1 |
| 141 | cisplatin-based | 390 |
| 142 | non-cisplatin-based | 5 |
| 143 | noncisplatin-based | 2 |
| 144 | go-based | 2 |
| 145 | nap-based | 1 |
| 146 | cddp-based | 4 |
| 147 | ndp-based | 2 |
| 148 | chop-based | 1 |
| 149 | l-asp-based | 1 |
| 150 | anti-egfr-based | 2 |
| 151 | indinavir-based | 1 |
| 152 | alkylator-based | 10 |
| 153 | taxanes-based | 5 |
| 154 | anthracyclines-based | 3 |
| 155 | ilps-based | 1 |
| 156 | limbus-based | 1 |
| 157 | temsirolimus-based | 1 |
| 158 | t-based | 3 |
| 159 | doublet-based | 1 |
| 160 | fu-based | 6 |
| 161 | 5-fu-based | 68 |
| 162 | sc-ril-2/sc-rifn-alpha2a/iv-5-fu-based | 1 |
| 163 | 5fu-based | 8 |
| 164 | folfox-based | 3 |
| 165 | hd-mtx-based | 6 |
| 166 | chemotherapy-based | 11 |
| 167 | hepatic-artery-based | 1 |
| 168 | tmz-based | 4 |
| 169 | efavirenz-based | 32 |
| 170 | conventionally-dosed | 2 |
| 171 | frequently-repeated | 2 |
| 172 | vglut2-mediated | 5 |
| 173 | glial-mediated | 2 |
| 174 | dose-escalated | 33 |
| 175 | sit-related | 1 |
| 176 | normofractionated | 1 |
| 177 | hypofractionated | 161 |
| 178 | lymphoma-directed | 3 |
| 179 | bone-directed | 5 |
| 180 | cns-directed | 6 |
| 181 | antibody-directed | 9 |
| 182 | thermo-targeted | 2 |
| 183 | 12-step-oriented | 2 |
| 184 | g-csf-supported | 1 |
| 185 | stem-cell-supported | 1 |
| 186 | double-boosted | 1 |
| 187 | non-pemetrexed | 2 |
| 188 | sirt+standard | 1 |
| 189 | current-standard | 1 |
| 190 | induction-maintenance | 15 |
| 191 | carboplatin/ifosfamide | 2 |
| 192 | epirubicin-paclitaxel-cyclophosphamide | 1 |
| 193 | non-temozolomide | 1 |
| 194 | involved-node | 3 |
| 195 | capecitabine-free | 7 |
| 196 | nrti-free | 1 |
| 197 | interval-free | 1 |
| 198 | ifn-free | 14 |
| 199 | interferon-free | 49 |
| 200 | ifn-α-free | 1 |
| 201 | 2-dosage | 1 |
| 202 | higher-cumulative-dosage | 1 |
| 203 | lower-dosage | 2 |
| 204 | vad-like | 1 |
| 205 | abvd-like | 2 |
| 206 | copp/abvd-like | 1 |
| 207 | chop-like | 6 |
| 208 | r-chop-like | 5 |
| 209 | effective/tolerable | 1 |
| 210 | intravesicle | 1 |
| 211 | charged-particle | 6 |
| 212 | 6-cycle | 3 |
| 213 | multicycle | 6 |
| 214 | amoxicillin-nitroimidazole | 1 |
| 215 | amoxicillin-metronidazole | 3 |
| 216 | anthracycline-taxane | 5 |
| 217 | pre-taxane | 1 |
| 218 | platinum-taxane | 7 |
| 219 | non-taxane | 16 |
| 220 | gemcitabine/epirubicin/taxane | 1 |
| 221 | erlotinib/capecitabine | 1 |
| 222 | platinum-gemcitabine | 3 |
| 223 | vinorelbine/gemcitabine | 3 |
| 224 | immunocytokine | 2 |
| 225 | 2nd-line | 12 |
| 226 | sclc.second-line | 1 |
| 227 | higher-line | 1 |
| 228 | dose-dense | 158 |
| 229 | 'dose-dense | 2 |
| 230 | intensified/dose-dense | 1 |
| 231 | more-intense | 6 |
| 232 | dose-intense | 21 |
| 233 | dentifrice/mouthrinse | 1 |
| 234 | therapeutic-dose | 3 |
| 235 | medium-to-high-dose | 1 |
| 236 | r-high-dose | 1 |
| 237 | low-lose | 1 |
| 238 | five-course | 1 |
| 239 | shorter-course | 7 |
| 240 | split-course | 36 |
| 241 | ultra-short-course | 3 |
| 242 | first-course | 3 |
| 243 | anti-folate | 2 |
| 244 | neoadjuvante | 2 |
| 245 | aplasive | 1 |
| 246 | dose-intensive | 53 |
| 247 | myelosuppressive | 52 |
| 248 | adjuvant/palliative | 1 |
| 249 | myeloablative | 158 |
| 250 | nonmyeloablative | 30 |
| 251 | resective/regenerative | 2 |
| 252 | biopsy/pre-operative | 1 |
| 253 | neoadjuvant/preoperative | 1 |
| 254 | neoadjunctive | 1 |
| 255 | ptz-sensitive | 1 |
| 256 | cholecystokinin-positive | 1 |
| 257 | bleed-preventive | 2 |
| 258 | x-solve | 1 |
| 259 | effectof | 1 |
| 260 | p-g | 1 |
| 261 | golfig | 5 |
| 262 | senescence-inducing | 1 |
| 263 | mucositis-inducing | 1 |
| 264 | serotonin-producing | 1 |
| 265 | pasture-feeding | 1 |
| 266 | estrogen-mimicking | 1 |
| 267 | anti-cd20-containing | 1 |
| 268 | hydroxyurea-containing | 2 |
| 269 | ifn-alpha-containing | 2 |
| 270 | rituximab-containing | 14 |
| 271 | bevacizumab-containing | 27 |
| 272 | non-bevacizumab-containing | 2 |
| 273 | trastuzumab-containing | 17 |
| 274 | anthracycline-trastuzumab-containing | 1 |
| 275 | sorafenib-containing | 3 |
| 276 | abc-containing | 3 |
| 277 | delamanid-containing | 1 |
| 278 | pld-containing | 1 |
| 279 | ifosfamide-containing | 1 |
| 280 | non-ifosfamide-containing | 1 |
| 281 | cyclophosphamide-containing | 2 |
| 282 | repaglinide-containing | 1 |
| 283 | ceftazidime-containing | 3 |
| 284 | taxane-containing | 36 |
| 285 | non-taxane-containing | 10 |
| 286 | cytarabine-containing | 5 |
| 287 | capecitabine-containing | 10 |
| 288 | emtricitabine-containing | 2 |
| 289 | fluoropyrimidine-containing | 3 |
| 290 | zidovudine/lamivudine-containing | 1 |
| 291 | anthracycline-containing | 73 |
| 292 | non-anthracycline-containing | 5 |
| 293 | paclitaxel/anthracycline-containing | 1 |
| 294 | doxycycline-containing | 2 |
| 295 | quinolone-containing | 1 |
| 296 | non-tdf-containing | 1 |
| 297 | 5ari-containing | 1 |
| 298 | intraperitoneal-containing | 1 |
| 299 | docetaxel-containing | 15 |
| 300 | paclitaxel-containing | 14 |
| 301 | fluorouracil-containing | 5 |
| 302 | chlorambucil-containing | 1 |
| 303 | platinum-containing | 50 |
| 304 | paclitaxel/platinum-containing | 1 |
| 305 | nonplatinum-containing | 1 |
| 306 | irinotecan-containing | 15 |
| 307 | oxaliplatin-/irinotecan-containing | 2 |
| 308 | nonirinotecan-containing | 1 |
| 309 | epirubicin-containing | 7 |
| 310 | doxorubicin-containing | 12 |
| 311 | rifampicin-containing | 11 |
| 312 | adriamycin-containing | 2 |
| 313 | azithromycin-containing | 5 |
| 314 | anthracycline/mitomycin-containing | 1 |
| 315 | anthracyclin-containing | 1 |
| 316 | artemisinin-containing | 1 |
| 317 | non-platin-containing | 1 |
| 318 | oxaliplatin-containing | 10 |
| 319 | carboplatin-containing | 4 |
| 320 | cisplatin-containing | 38 |
| 321 | interferon-containing | 7 |
| 322 | ondansetron-containing | 1 |
| 323 | placebo-containing | 2 |
| 324 | cddp-containing | 2 |
| 325 | gp-containing | 1 |
| 326 | lpv/r-containing | 6 |
| 327 | atazanavir/ritonavir-containing | 1 |
| 328 | ics-containing | 2 |
| 329 | 5-fu-containing | 7 |
| 330 | bev-containing | 1 |
| 331 | atv-containing | 2 |
| 332 | dox-containing | 1 |
| 333 | nonefavirenz-containing | 1 |
| 334 | furosemide-sparing | 1 |
| 335 | glucose-sparing | 1 |
| 336 | remote-monitoring | 1 |
| 337 | anthracycline-comprising | 3 |
| 338 | metabolism-regulating | 2 |
| 339 | non-alkylating | 1 |
| 340 | nonalkylating | 3 |
| 341 | indirect-acting | 2 |
| 342 | fast-reacting | 1 |
| 343 | receive/receiving | 1 |
| 344 | immune-system-modifying | 1 |
| 345 | prognosis-modifying | 2 |
| 346 | one-year-long | 1 |
| 347 | double-drug | 8 |
| 348 | indirectly-with | 1 |
| 349 | non-i | 1 |
| 350 | introvesical | 1 |
| 351 | anti-tritrichomonial | 1 |
| 352 | timed-sequential | 1 |
| 353 | pontospinal | 1 |
| 354 | ato/conventional | 1 |
| 355 | chemo-hormonal | 3 |
| 356 | septo-hippocampal | 1 |
| 357 | subscleral | 1 |
| 358 | all-oral | 25 |
| 359 | standard-interval | 1 |
| 360 | platinum-paclitaxel | 6 |
| 361 | non-paclitaxel | 3 |
| 362 | cisplatin-hdfl | 1 |
| 363 | methotrexate-5-fluorouracil | 1 |
| 364 | leucovorin/5-fluorouracil | 1 |
| 365 | cisplatin-fluorouracil | 5 |
| 366 | fluorouacil | 1 |
| 367 | gemfufol | 3 |
| 368 | 3-n-hydroxymethyl | 1 |
| 369 | nicoderm | 3 |
| 370 | gemcitabine-platinum | 13 |
| 371 | docetaxel-platinum | 3 |
| 372 | irinotecan-platinum | 1 |
| 373 | combination-platinum | 6 |
| 374 | non-platinum | 44 |
| 375 | pemetrexed-plus-platinum | 1 |
| 376 | pemetrexed/platinum | 8 |
| 377 | paclitaxel/platinum | 7 |
| 378 | non-topotecan | 1 |
| 379 | periodontitis-driven | 1 |
| 380 | cisplatin-etoposide-bleomycin | 1 |
| 381 | platinum-vinblastine-bleomycin | 1 |
| 382 | 5-fluorouracil/mitomycin | 2 |
| 383 | levofloxacin-amoxicillin | 2 |
| 384 | non-oxaliplatin | 1 |
| 385 | irinotecan/oxaliplatin | 2 |
| 386 | paclitaxel-cisplatin | 7 |
| 387 | zmyl-cisplatin | 1 |
| 388 | non-cisplatin | 6 |
| 389 | eisplatin | 1 |
| 390 | trials-herceptin | 1 |
| 391 | oestrogens-progestin | 1 |
| 392 | maintenance/consolidation | 5 |
| 393 | preenucleation | 1 |
| 394 | chemotherapy/radiation | 2 |
| 395 | orpostradiation | 1 |
| 396 | platinum-combination | 2 |
| 397 | aspirin-combination | 3 |
| 398 | 16-fraction | 1 |
| 399 | single-fraction | 24 |
| 400 | multiple-fraction | 2 |
| 401 | multifraction | 28 |
| 402 | intensive-induction | 1 |
| 403 | remission-induction | 10 |
| 404 | post-dilution | 21 |
| 405 | duvaxyn | 3 |
| 406 | pacco | 3 |
| 407 | observation/no | 2 |
| 408 | efavirenz-to | 1 |
| 409 | iv/ip | 2 |
| 410 | rchop | 2 |
| 411 | tam+hcq | 3 |
| 412 | epimacular | 2 |
| 413 | intraganglionar | 3 |
| 414 | whole-bladder | 2 |
| 415 | forewater | 1 |
| 416 | to/during/after | 1 |
| 417 | adminster | 1 |
| 418 | home-exercises | 2 |
| 419 | tpz/cis | 7 |
| 420 | capecitabine/bolus | 2 |
| 421 | 26-days | 1 |
| 422 | freund׳s | 1 |
| 423 | non-asct | 2 |
| 424 | doublet | 263 |
| 425 | platinum-doublet | 15 |
| 426 | y-90-it | 4 |
| 427 | conventional-adult | 2 |
| 428 | nsaid-anticoagulant | 2 |
| 429 | antithrombotic/anticoagulant | 1 |
| 430 | noncross-resistant | 5 |
| 431 | adjuvant | 9,072 |
| 432 | 'adjuvant | 2 |
| 433 | neo-adjuvant | 107 |
| 434 | concurrent-adjuvant | 5 |
| 435 | neoadjuvant/adjuvant | 8 |
| 436 | neoadjuvant | 2,148 |
| 437 | preoperative/neoadjuvant | 1 |
| 438 | adjuvant/neoadjuvant | 11 |
| 439 | preneoadjuvant | 2 |
| 440 | postneoadjuvant | 2 |
| 441 | naodjuvant | 1 |
| 442 | neodjuvant | 2 |
| 443 | 2-agent | 3 |
| 444 | single-agent | 725 |
| 445 | multiple-agent | 3 |
| 446 | alkylating-agent | 1 |
| 447 | multi-agent | 28 |
| 448 | combination-agent | 2 |
| 449 | multiagent | 48 |
| 450 | asthma-treatment | 1 |
| 451 | induction-concurrent | 3 |
| 452 | upfront | 189 |
| 453 | ddp+5-fu | 1 |
| 454 | docetaxel-cisplatin-5-fu | 1 |
| 455 | folfox/folfiri/xelox | 1 |
| 456 | non-hdtx | 1 |
| 457 | ac→tx | 1 |
| 458 | standard-efficacy | 2 |
| 459 | fac-only | 1 |
| 460 | nrti-only | 1 |
| 461 | postlumpectomy | 4 |
| 462 | supraclavicular/axillary | 1 |
| 463 | hepatic-artery | 2 |
| 464 | preirradiatory | 1 |
| 465 | |±3/2〉 | 1 |
| 466 | 28℃± | 1 |